KKR Genetic Disorder L.P.

Average Profitability
7.23%
Insider Buys Quantity
1
Insider Buys Sum
$90M
Insider Sells Quantity
3
Insider Sells Sum
$517.55M

Insider Activity of KKR Genetic Disorder L.P.

According to the SEC Form 4 filings, KKR Genetic Disorder L.P., being in a position of

  1. 10 percent owner at BridgeBio Pharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 5800000 shares for $149.35M,
    over all time since 2019-07-01, has bought 5294200 shares for $90M, and sold 14029380 shares for $517.55M.

The largest purchase of all time was on 2019-07-01 and amounted to 5294200 shares of BridgeBio Pharma, Inc. for $90M.

The largest sale of all time was on 2021-02-17 and amounted to 3450000 shares of BridgeBio Pharma, Inc. for $208.62M.

Biography of KKR Genetic Disorder L.P.

No biography is available at this moment.

2024-09-13SaleBridgeBio Pharma, Inc.
BBIO
10 percent owner
5.8M
3.0339%
$25.75$149.35M-3.02%
2021-02-17SaleBridgeBio Pharma, Inc.
BBIO
10 percent owner
3.45M
2.3252%
$60.47$208.62M-21.37%
2020-05-28SaleBridgeBio Pharma, Inc.
BBIO
10 percent owner
4.78M
3.8844%
$33.39$159.58M+33.81%
2019-07-01PurchaseBridgeBio Pharma, Inc.
BBIO
10 percent owner
5.29M
2.8088%
$17.00$90M+7.23%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.